View Item 

Show simple item record

Early hospital discharge of infants born to group B streptococci‐positive mothers: a decision analysis
dc.contributor.authorBerger, M. B.en_US
dc.contributor.authorXu, Xen_US
dc.contributor.authorWilliams, J. A.en_US
dc.contributor.authorVan de Ven, CJMen_US
dc.contributor.authorMozurkewich, ELen_US
dc.date.accessioned2012-03-16T15:54:50Z
dc.date.available2013-05-01T17:24:42Zen_US
dc.date.issued2012-03en_US
dc.identifier.citationBerger, MB; Xu, X; Williams, JA; Van de Ven, CJM; Mozurkewich, EL (2012). "Early hospital discharge of infants born to group B streptococci‐positive mothers: a decision analysis." BJOG: An International Journal of Obstetrics & Gynaecology 119(4). <http://hdl.handle.net/2027.42/90120>en_US
dc.identifier.issn1470-0328en_US
dc.identifier.issn1471-0528en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90120
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.subject.otherSepsisen_US
dc.subject.otherHealthcare Costsen_US
dc.subject.otherStreptococcus Agalactiaeen_US
dc.subject.otherPostpartum Perioden_US
dc.subject.otherPatient Dischargeen_US
dc.titleEarly hospital discharge of infants born to group B streptococci‐positive mothers: a decision analysisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelObstetrics and Gynecologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Obstetrics and Gynecology, University of Michigan Health Systemen_US
dc.contributor.affiliationotherDepartment of Obstetrics and Gynecology, St Joseph Mercy Health System, Ann Arbor, MI, USAen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90120/1/j.1471-0528.2011.03249.x.pdf
dc.identifier.doi10.1111/j.1471-0528.2011.03249.xen_US
dc.identifier.sourceBJOG: An International Journal of Obstetrics & Gynaecologyen_US
dc.identifier.citedreferenceErickson P, Wilson R, Shannon I. Years of healthy life. Healthy People 2000 Stat Notes 1995; 7: 1 – 15.en_US
dc.identifier.citedreferenceKatz RT. Life expectancy for children with cerebral palsy and mental retardation: implications for life care planning. NeuroRehabilitation 2003; 18: 261 – 70.en_US
dc.identifier.citedreferenceCarroll AE, Downs SM. Comprehensive cost–utility analysis of newborn screening strategies. Pediatrics 2006; 117: S287 – 95.en_US
dc.identifier.citedreferencede Lissovoy G, Matza LS, Green H, Werner M, Edgar T. Cost‐effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy. J Child Neurol 2007; 22: 49 – 59.en_US
dc.identifier.citedreferencePham CT, Crowther CA. Birth outcomes: utility values that postnatal women, midwives and medical staff express. BJOG 2003; 110: 1217.en_US
dc.identifier.citedreferencePlatt R, Adelson‐Mitty J, Weissman L, Zaleznik D, Lee ML, Baker CJ. Resource utilization associated with initial hospital stays complicated by early onset group B streptococcal disease. Pediatr Infect Dis J 1999; 18: 529 – 33.en_US
dc.identifier.citedreferenceMayor‐Lynn K, Gonzalez‐Quintero VH, O’Sullivan MJ, Hartstein AI, Roger S, Tamayo M. Comparison of early‐onset neonatal sepsis caused by Escherichia coli and group B Streptococcus. Am J Obstet Gynecol 2005; 192: 1437 – 9.en_US
dc.identifier.citedreferenceConsumer Price Index – CPI (All Urban Consumers). [ http://www.bls.gov/cpi ]. Accessed 26 September 2011.en_US
dc.identifier.citedreferenceWeinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost‐effectiveness in Health and Medicine. JAMA 1996; 276: 1253 – 8.en_US
dc.identifier.citedreferencePalisade Corporation. Guide to using @RISK: Risk Analysis and Simulation Add‐in for Microsoft Excel. Ithaca, NY: Palisade Corporation, 2008.en_US
dc.identifier.citedreferenceLord J, Asante MA. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis. Health Econ 1999; 8: 323 – 33.en_US
dc.identifier.citedreferenceBrouwer WB, Koopmanschap MA, Rutten FF Productivity costs in cost‐effectiveness analysis: numerator or denominator: a further discussion. Health Econ. 1997; 6: 511 – 4.en_US
dc.identifier.citedreferenceRothermich EA, Pathak DS. Productivity–cost controversies in cost‐effectiveness analysis: review and research agenda. Clin Ther 1999; 21: 255 – 67.en_US
dc.identifier.citedreferenceTilling C, Krol M, Tsuchiya A, Brazier J, Brouwer W. In or out? Income losses in health state valuations: a review Value Health 2010; 13: 298 – 305.en_US
dc.identifier.citedreferenceNyman JA. Productivity Costs Revisited: Toward a New Us Policy. Health Econ. 2011; DOI: 10.1002/hec.1795. [Epub ahead of print].en_US
dc.identifier.citedreferenceHirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG. Willingness to pay for a quality‐adjusted life year: in search of a standard. Med Decis Making 2000; 20: 332 – 42.en_US
dc.identifier.citedreferenceFargason CA Jr, Peralta‐Carcelen M, Rouse DJ, Cutter GR, Goldenberg RL. The pediatric costs of strategies for minimizing the risk of early‐onset group B streptococcal disease. Obstet Gynecol 1997; 90: 347 – 52.en_US
dc.identifier.citedreferenceCommittee on Fetus and newborn. Hospital stay for healthy term newborns. Pediatrics 2010; 125: 405 – 9.en_US
dc.identifier.citedreferenceMadden JM. Effects of a law against early postpartum discharge on newborn follow‐up, adverse events, and HMO expenditures. N Engl J Med 2002; 347: 2031 – 8.en_US
dc.identifier.citedreferenceMeara E, Kotagal UR, Atherton HD, Lieu TA. Impact of early newborn discharge legislation and early follow‐up visits on infant outcomes in a state Medicaid population. Pediatrics 2004; 113: 1619 – 27.en_US
dc.identifier.citedreferenceMadden JM, Soumerai SB, Lieu TA, Mandl KD, Zhang F, Ross‐Degnan D. Length‐of‐stay policies and ascertainment of postdischarge problems in newborns. Pediatrics 2004; 113: 42 – 9.en_US
dc.identifier.citedreferenceBrown S, Small R, Argus B, Davis PG, Krastev A Early postnatal discharge from hospital for healthy mothers and term infants. Cochrane Database Syst Rev 2009; 2:CD002958.en_US
dc.identifier.citedreferenceChernew ME, Hirth RA, Cutler DM. Increased spending on health care: how much can the United States afford? Health Aff (Millwood) 2003; 22: 15 – 25.en_US
dc.identifier.citedreferenceMeltzer D, Johannesson M. Inconsistencies in the “societal perspective” on costs of the Panel on Cost‐Effectiveness in Health and Medicine. Med Decis Making 1999; 19: 371 – 7.en_US
dc.identifier.citedreferenceSculpher M. The use of quality‐adjusted life‐years in cost‐effectiveness studies. Allergy 2006; 61: 527 – 30.en_US
dc.identifier.citedreferenceDepartment of Health and Human Services. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep 1996; 45: 1 – 24.en_US
dc.identifier.citedreferenceDepartment of Health and Human Services. Early‐onset and late‐onset neonatal group B streptococcal disease—United States, 1996–2004. MMWR Morb Mortal Wkly Rep 2005; 54: 1205 – 8.en_US
dc.identifier.citedreferenceGotoff SP. Group B streptococcal infections. Pediatr Rev 2002; 23: 381 – 6.en_US
dc.identifier.citedreferenceMullaney DM. Group B streptococcal infections in newborns. J Obstet Gynecol Neonatal Nurs 2001; 30: 649 – 58.en_US
dc.identifier.citedreferenceOhlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2009; 3: CD007467.en_US
dc.identifier.citedreferenceVerani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59: 1 – 36.en_US
dc.identifier.citedreferenceSchrag S, Gorwitz R, Fultz‐Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51: 1 – 22.en_US
dc.identifier.citedreferenceSchrag SJ, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol 2000; 21: 473 – 83.en_US
dc.identifier.citedreferenceTumbaga PF, Philip AGS. Perinatal Group B Streptococcal Infections and the new guidelines: an update. Neoreviews 2006; 7: e524 – 30.en_US
dc.identifier.citedreferenceBaker CJ. CDC revises group B strep prevention guidelines. AAP News 2002; 21: 118.en_US
dc.identifier.citedreferenceGlasgow TS, Speakman M, Firth S, James B, Byington CL, Young PC. Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers. Paediatr Perinat Epidemiol 2007; 21: 338 – 46.en_US
dc.identifier.citedreferenceRenner RM, Renner A, Schmid S, Hoesli I, Nars P, Holzgreve W, et al. Efficacy of a strategy to prevent neonatal early‐onset group B streptococcal (GBS) sepsis. J Perinat Med 2006; 34: 32 – 8.en_US
dc.identifier.citedreferenceVelaphi S, Siegel JD, Wendel GD Jr, Cushion N, Eid WM, Sanchez PJ. Early‐onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics 2003; 111: 541 – 7.en_US
dc.identifier.citedreferenceBaltimore RS, Huie SM, Meek JI, Schuchat A, O’Brien KL. Early‐onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001; 108: 1094 – 8.en_US
dc.identifier.citedreferenceApgar BS, Greenberg G, Yen G. Prevention of group B streptococcal disease in the newborn. Am Fam Physician 2005; 71: 903 – 10.en_US
dc.identifier.citedreferenceEscobar GJ, Li DK, Armstrong MA, Gardner MN, Folck BF, Verdi JE, et al. Neonatal sepsis workups in infants >/=2000 grams at birth: a population‐based study. Pediatrics 2000; 106: 256 – 63.en_US
dc.identifier.citedreferenceTrijbels‐Smeulders M, Gerards LJ, Pasker‐de Jong PCM, de Jong P, van Lingen RA, Adriaanse AH, et al. Epidemiology of neonatal group B streptococcal disease in The Netherlands 1997–98. Paediatr Perinat Epidemiol 2002; 16: 334 – 41.en_US
dc.identifier.citedreferenceBromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. The influence of intrapartum antibiotics on the clinical spectrum of early‐onset group B streptococcal infection in term infants. Pediatrics 2000; 106: 244 – 50.en_US
dc.identifier.citedreferenceChen KT, Ringer S, Cohen AP, Lieberman E. The role of intrapartum fever in identifying asymptomatic term neonates with early‐onset neonatal sepsis. J Perinatol 2002; 22: 653 – 7.en_US
dc.identifier.citedreferenceZaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee ML, et al. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis 2000; 30: 276 – 81.en_US
dc.identifier.citedreferenceHeath PT, Balfour GF, Tighe H, Verlander NQ, Lamagni TL, Efstratiou A, et al. Group B streptococcal disease in infants: a case control study. Arch Dis Child 2009; 94: 674 – 80.en_US
dc.identifier.citedreferenceBerardi A, Lugli L, Baronciani D, Rossi C, Ciccia M, Creti R, et al. Group B Streptococcus early‐onset disease in Emilia‐romagna: review after introduction of a screening‐based approach. Pediatri Infect Dis J 2010; 29: 115 – 21.en_US
dc.identifier.citedreferenceSchrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15 – 20.en_US
dc.identifier.citedreferenceMifsud AJ, Efstratiou A, Charlett A, McCartney AC. Early‐onset neonatal group B streptococcal infection in London: 1990–1999. BJOG 2004; 111: 1006 – 11.en_US
dc.identifier.citedreferenceOddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case‐control study. BMJ 2002; 325: 308.en_US
dc.identifier.citedreferenceSchuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O’Sullivan MJ, et al. Risk factors and opportunities for prevention of early‐onset neonatal sepsis: a multicenter case–control study. Pediatrics 2000; 105: 21 – 6.en_US
dc.identifier.citedreferenceFluegge K, Siedler A, Heinrich B, Schulte‐Moenting J, Moennig MJ, Bartels DB, et al. Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics 2006; 117: e1139 – 45.en_US
dc.identifier.citedreferenceGibbs RS, Schrag S, Schuchat A. Perinatal infections due to group B streptococci. Obstet Gynecol 2004; 104: 1062 – 76.en_US
dc.identifier.citedreferenceRemington JS, Klein JO. Infectious diseases of the fetus and newborn infant. Philadelphia: Saunders, 2001.en_US
dc.identifier.citedreferenceAkker‐van Marle ME, Rijnders ME, Dommelen P, Fekkes M, Wouwe JP, Amelink‐Verburg MP, et al. Cost‐effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early‐onset group B streptococcal disease. BJOG 2005; 112: 820 – 6.en_US
dc.identifier.citedreferenceMohle‐Boetani JC, Lieu TA, Ray GT, Escobar G. Preventing neonatal group B streptococcal disease: cost‐effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics 1999; 103: 703 – 10.en_US
dc.identifier.citedreferenceEvans WN, Garthwaite C, Wei H. The impact of early discharge laws on the health of newborns. J Health Econ 2008; 27: 843 – 70.en_US
dc.identifier.citedreferenceHospital Outpatient PPS [ http://www.cms.gov/HospitalOutpatientPPS ]. Accessed 30 September 2011.en_US
dc.identifier.citedreferencePhysician Fee Schedule. [ http://www.cms.gov/PhysicianFeeSched ]. Accessed 30 September 2011.en_US
dc.identifier.citedreferenceAcute Inpatient PPS – FY2010 Final Rule Home Page. [ http://www.cms.gov/AcuteInpatientPPS/10FR/list.asp#TopOfPage ]. Accessed 30 September 2011.en_US
dc.identifier.citedreferenceTurrentine MA, Ramirez MM, Mastrobattista JM. Cost‐effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization. Infect Dis Obstet Gynecol 2009; 2009:934698.en_US
dc.identifier.citedreferenceHoneycutt AA, Grosse SD, Dunlap LJ, Schendel DE, Chen H, Brann E, et al. Economic costs of mental retardation, cerebral palsy, hearing loss, and vision impairment. In: Altman BM, Barnartt SN, Henderschot G, Larson S, editors. Using Survey Data to Study Disability: Results from the National Health Interview Survey on Disability. London: Elsevier Science, Ltd.; 2003. pp. 207 – 28.en_US
dc.identifier.citedreferenceHighlight of Women’s Earnings in 2010. July 2011. Report 1031. [ http://www.bls.gov/cps/cpswom2010.pdf ]. Accessed 5 October 2011.en_US
dc.identifier.citedreferenceArias E. United States life tables, 2004. Natl Vital Stat Rep 2007; 56: 1 – 39.en_US
dc.identifier.citedreferenceXu J, Kochanek KD, Murphy SL, Tejada‐Vera B. Deaths: final data for 2007. In: U.S. Department of Health and Human Services CfDCaP, National Center for Health Statistics, National Vital Statistics System, editor. National Vital Statistics Report. Washington D.C.: U.S. Department of Health and Human Services; 2010. pp. 1 – 136.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1471-0528.2011.03249.x.pdf
Size:
245.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.